Sign in

You're signed outSign in or to get full access.

José-Marie Griffiths

Director at DAKTRONICS INC /SD/
Board

About José‑Marie Griffiths

Independent director at Daktronics since September 2020; age 73 as of the Record Date. President of Dakota State University (since July 2015), with a background spanning research, teaching, public service, and technology leadership; degrees include a B.Sc. and Ph.D. from University College London and a post‑doctoral fellowship in Computer Science and Statistics, with recent honorary D.Sc. from UCL . Core credentials include cybersecurity and artificial intelligence expertise, service on the National Science Board, U.S. President’s Information Technology Advisory Committee, U.S. National Commission on Libraries and Information Science, and appointment to the National Security Commission on Artificial Intelligence in 2018 .

Past Roles

OrganizationRoleTenureCommittees/Impact
National Science BoardPresidential appointee/memberNot disclosedFederal science governance and oversight
U.S. President’s Information Technology Advisory CommitteePresidential appointee/memberNot disclosedNational IT policy advisory
U.S. National Commission on Libraries and Information SciencePresidential appointee/memberNot disclosedInformation science policy advisory
National Security Commission on Artificial IntelligenceCommissionerAppointed 2018AI strategy, national security policy

External Roles

OrganizationRoleTenureScope/Impact
Dakota State UniversityPresidentSince July 2015University leadership; related‑party exposure via DSU display contracts with Daktronics
Various U.S. federal agencies (e.g., NSF, NASA, DOE)Project leader/PINot disclosedLed projects across 28+ federal agencies and 20+ major corporations in 35+ countries; worked with NATO and UN

Board Governance

  • Independence: Determined independent under Nasdaq Rule 5605(a)(2) .
  • Years of service: Director since September 2020 .
  • Committee memberships and chair roles:
    • Compensation Committee member since September 2020 .
    • Nominating Committee member (Sep 2020–Mar 2024) and Chairperson since March 2024 .
    • Strategy & Risk Committee member since March 2024 .
  • Attendance and engagement: All incumbent directors attended ≥75% of Board and committee meetings; Board held 8 regular and 15 special meetings; Compensation Committee met 20 times; Nominating met 4 times; Strategy & Risk met 5 times; independent director executive sessions held four times in FY2025 .
  • Board leadership context: Independent Chair (Andrew Siegel); Lead Independent Director role eliminated in March 2025 as part of revised leadership structure .

Fixed Compensation

Component (FY2025)Amount ($)Notes
Annual cash retainer53,750Independent director retainer
Nominating Committee chair fee7,250Chair fee
Compensation Committee membership fee4,675Member fee
Strategy & Risk Committee membership fee4,675Member fee
Total cash fees70,350Sum reported for Dr. Griffiths in director comp table

Performance Compensation

Grant TypeGrant DateSharesGrant‑Date Fair Value ($)Vesting
Restricted Stock (annual director grant)Sep 9, 20247,16085,000Vests Aug 23, 2025 if serving as director on vesting date; grant‑date FV $11.87/share
Note on dividendsDividends accrue on restricted stock under the 2025 Plan; paid only upon vesting (plan‑level terms)

FY2025 director compensation mix: cash $70,350 and equity $85,000 (≈45% cash / 55% equity), supporting alignment with shareholder outcomes through equity exposure .

Other Directorships & Interlocks

  • Other public company directorships: None disclosed for Dr. Griffiths in the proxy biography and director listings .
  • Related‑party transactions:
    • Dakota State University contracts for video display systems in FY2024 totaling $1.2 million; terms described as arm’s‑length and ordinary course; Dr. Griffiths is DSU President .
  • Governance controls: Related Person Transaction Policy overseen by the Audit Committee; transactions >$120,000 reviewed/approved; annual review of ongoing related‑party transactions .

Expertise & Qualifications

  • Technology expertise: Cybersecurity and AI; leadership across federal civilian/military agencies and international organizations (NATO, UN) .
  • Academic leadership: DSU president with global project leadership experience .
  • Qualifications fit committee roles: Governance (Nominating Chair), strategy and risk oversight (Strategy & Risk Committee), compensation oversight (Compensation Committee) .

Equity Ownership

MetricValue
Total beneficial ownership (shares)57,495; includes 7,160 restricted shares scheduled to vest Aug 23, 2025
Shares outstanding (Record Date)49,120,799
Ownership as % of shares outstanding~0.12% (57,495 / 49,120,799)
Vested vs unvested breakdownUnvested restricted shares: 7,160 scheduled to vest Aug 23, 2025
OptionsNone disclosed for Dr. Griffiths in director holdings
Stock ownership guideline20,000 shares required within 5 years; all directors in compliance except newly appointed Peter Feigin
Compliance statusIn compliance with director ownership guideline
Hedging/pledgingHedging and short sales prohibited under Trading Policy; no pledging disclosed

Insider Trades

ItemStatus
Section 16(a) compliance (FY2025)No late filings reported for Dr. Griffiths; late filers listed did not include Dr. Griffiths

Governance Assessment

  • Strengths
    • Independent director with deep technology and AI/cybersecurity credentials; Chairs Nominating and serves on Strategy & Risk and Compensation—signal of strong governance and risk oversight .
    • High engagement: Board and committee cadence was intensive; all incumbents ≥75% attendance, with frequent executive sessions of independent directors .
    • Ownership alignment: Beneficial ownership of 57,495 shares and compliance with 20,000‑share guideline; annual equity grants time‑vested to reinforce alignment .
  • Potential risks / RED FLAGS
    • Related‑party exposure: DSU contracts ($1.2M in FY2024) while serving as DSU President—mitigated by Audit Committee oversight and RPT Policy and described as arm’s‑length; monitor for recurrence and approval rigor .
    • Equity vesting mechanics: Director equity grants are time‑based restricted stock (no performance conditions), which may modestly reduce pay‑for‑performance sensitivity; however, equity exposure remains a positive alignment factor .
  • Process controls
    • Robust governance framework (independent Chair; committee structure; executive sessions; clawback policy for executives; hedging prohibition) supports investor confidence .

Overall: Dr. Griffiths’ independence, committee leadership, and technology expertise strengthen board effectiveness; related‑party DSU transactions merit continued scrutiny but are governed under established policies and oversight, with clear disclosures indicating arm’s‑length terms .